FDA issues emergency use authorization to Regeneron for COVID antibody treatment
The U.S. Food and Drug Administration (FDA) issued an emergency use authorization to Regeneron Pharmaceuticals for its monoclonal...
top of page
Inspiring independence with
respect and dignity
bottom of page